Screener
CG Oncology CGON Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Commercial and development revenue | $1,147 | — | $2,216 | — |
| License and collaboration revenue | 10 | — | 24 | 52 |
| Total revenues | 1,157 | — | 2,240 | 52 |
| Operating costs and expenses | ||||
| Cost of sales | 3,925 | — | 6,887 | — |
| Research and development | 54,657 | 31,331 | 98,387 | 58,799 |
| General and administrative | 28,976 | 17,410 | 49,756 | 32,198 |
Item 1. Financial Statements.
FAQ
- What is CG Oncology's total revenue?
- CG Oncology (CGON) reported total revenue of $1.16M in Q2 2026.
- What is the long-term trend for CG Oncology's total revenue?
- Over 2 years (2023 to 2025), CG Oncology's total revenue has grown at a 345.0% compound annual growth rate (CAGR), from $204K to $4.04M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about CG Oncology's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude